Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Shire PLC (NASDAQ:SHPG)

185.35
Delayed Data
As of May 24
 +0.36 / +0.19%
Today’s Change
161.09
Today|||52-Week Range
209.22
+8.79%
Year-to-Date
Ultragenyx Receives Priority Review for rhGUS from FDA
May 24 / Zacks.com - Paid Partner Content
Checking Out the Pre-Market Action
May 18 / TheStreet.com - Paid Partner Content
Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug
May 22 / Zacks.com - Paid Partner Content
Shire Stock Rises Premarket on Positive Phase 3 Results for Angiodema Treatment
May 18 / TheStreet.com - Paid Partner Content
Company News for May 19, 2017
May 19 / Zacks.com - Paid Partner Content
Sangamo's (SGMO) Hemophilia A Drug Gets Fast-Track Status
May 17 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More
May 19 / Zacks.com - Paid Partner Content
Merrimack (MACK) Q1 Loss Wider than Expected, Sells Onivyde
May 11 / Zacks.com - Paid Partner Content
Biotech Movers: Fast Track Designation Sends Sage Shares Higher
May 18 / TheStreet.com - Paid Partner Content